The Iroko Building Opens at Navy Yard Corporate Center
Iroko Pharmaceuticals, LLC, a Philadelphia-based pharmaceutical company focused on the development and commercialization of innovative therapeutic products, has moved to its new headquarters building at 150 Rouse Boulevard in The Navy Yard Corporate Center.
Developed to achieve LEED Gold certification, this is the seventh sustainable building to be developed in the complex by the team of Liberty Property Trust/Synterra Partners.
The 56,412 square foot, four-story facility features high performance systems designed to manage energy, atmosphere, water and indoor environmental quality. Built predominantly with locally-sourced materials, the facility will serve as the company’s global headquarters.
The building was designed to accommodate about 180 employees at maximum capacity.
Liberty has invested $15.4 million in the development of the project. In total, Liberty/Synterra has developed more than 1.02 million rentable square feet representing more than $240 million in private investment in The Navy Yard to date.
Liberty initially conceived The Iroko Building as an inventory office building. It was designed for Liberty/Synterra by DIGSAU, a Philadelphia-based design firm and constructed by Penn Construction Company.
The Navy Yard Corporate Center is a master-planned development within The Navy Yard featuring sustainable multi-tenant and build-to-suit office space, developed and owned by Liberty Property/Synterra, L.P., a joint venture between Liberty Property Trust and Synterra Partners. During the last eight years, six properties totaling over 580,000 square feet have been completed or are under construction in The Navy Yard Corporate Center representing an investment of approximately $180 million in development.
In addition, Liberty Property/Synterra has developed The Tasty Baking Facility and two high-finish flex buildings at The Navy Yard Commerce Center as well as two build-to-suit properties at Research Park in The Navy Yard for an additional investment of over $80 million.